Literature DB >> 12927874

Long-chain polyamines (oligoamines) exhibit strong cytotoxicities against human prostate cancer cells.

Aldonia Valasinas1, Venodhar K Reddy, Andrei V Blokhin, Hirak S Basu, Subhra Bhattacharya, Aparajita Sarkar, Laurence J Marton, Benjamin Frydman.   

Abstract

alpha N,(omega)N-bis(ethyl) octamine SL-11160, decamine SL-11159, dodecamine SL-11226, and tetradecamine SL-11175 were chemically synthesized. We called this class of compounds 'oligoamines'. In these compounds, each -NH(2)(+) residue is separated by four CH(2) residues. trans-Unsaturation was also introduced into the center of the oligoamine chain resulting in the trans-octamine SL-11158, trans-decamine SL-11144, trans-dodecamine SL-11172 and trans-tetradecamine SL-11227. cis-Unsaturation gave the cis-octamine SL-11157 and cis-decamine SL-11150. When assayed for their growth inhibitory effect against four human prostate cancer cell lines LnCap, DU-145, DuPro, and PC-3 by a MTT assay, the ID(50) values were less than 1 microM in all four cell lines. On day 6 of treatment, 2 microM SL-11159, SL-11144 and SL-11175 killed over five logs of DuPro cells while SL-11172 killed over four logs as determined by a colony forming efficiency (CFE) assay. In addition, SL-11159, SL-11226 and SL-11227 killed four logs of PC-3 cells. PC-3 cells are generally resistant to shorter chain polyamine analogues. Such a level of cytotoxicity in any of the prostate tumor cell lines has not been observed for any other polyamine analogues tested thus far. The DU-145 cell line was too sensitive to oligoamines to perform a CFE analysis and the DuPro cell line was too sensitive to SL-11227 treatment to obtain reproducible CFE data. Interestingly, all 10 oligoamines were efficient DNA aggregators in a cell-free system and their cytotoxicities generally parallel their capacities to aggregate DNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927874     DOI: 10.1016/s0968-0896(03)00453-x

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

Review 1.  Recent advances in the development of polyamine analogues as antitumor agents.

Authors:  Robert A Casero; Patrick M Woster
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

Review 2.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011

Review 3.  Polyamines and cancer: implications for chemotherapy and chemoprevention.

Authors:  Shannon L Nowotarski; Patrick M Woster; Robert A Casero
Journal:  Expert Rev Mol Med       Date:  2013-02-22       Impact factor: 5.600

4.  Role of p53/p21(Waf1/Cip1) in the regulation of polyamine analogue-induced growth inhibition and cell death in human breast cancer cells.

Authors:  Yi Huang; Allison Pledgie; Ethel Rubin; Laurence J Marton; Patrick M Woster; Saraswati Sukumar; Robert A Casero; Nancy E Davidson
Journal:  Cancer Biol Ther       Date:  2005-09-23       Impact factor: 4.742

5.  Alkyl-substituted polyaminohydroxamic acids: a novel class of targeted histone deacetylase inhibitors.

Authors:  Sheeba Varghese; Deepak Gupta; Tiffany Baran; Anchalee Jiemjit; Steven D Gore; Robert A Casero; Patrick M Woster
Journal:  J Med Chem       Date:  2005-10-06       Impact factor: 7.446

6.  Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cells.

Authors:  Yi Huang; Judith C Keen; Allison Pledgie; Laurence J Marton; Tao Zhu; Saraswati Sukumar; Ben Ho Park; Brian Blair; Keith Brenner; Robert A Casero; Nancy E Davidson
Journal:  J Biol Chem       Date:  2006-05-04       Impact factor: 5.157

7.  Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors.

Authors:  Sheeba Varghese; Thulani Senanayake; Tracey Murray-Stewart; Kim Doering; Alison Fraser; Robert A Casero; Patrick M Woster
Journal:  J Med Chem       Date:  2008-03-19       Impact factor: 7.446

8.  Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes.

Authors:  Yi Huang; Tracy Murray Stewart; Yu Wu; Stephen B Baylin; Laurence J Marton; Brandy Perkins; Richard J Jones; Patrick M Woster; Robert A Casero
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

Review 9.  Design of polyamine-based therapeutic agents: new targets and new directions.

Authors:  M D Thulani Senanayake; Hemali Amunugama; Tracey D Boncher; Robert A Casero; Patrick M Woster
Journal:  Essays Biochem       Date:  2009-11-04       Impact factor: 8.000

10.  Polyamine analogues: potent inducers of nucleosomal array oligomerization and inhibitors of yeast cell growth.

Authors:  Lenny M Carruthers; Laurence J Marton; Craig L Peterson
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.